Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001224891 | SCV001397117 | pathogenic | not provided | 2023-03-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change falls in intron 50 of the USH2A gene. It does not directly change the encoded amino acid sequence of the USH2A protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with retinitis pigmentosa and/or Usher syndrome (PMID: 26629787; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 952728). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 26629787). |
Baylor Genetics | RCV003469394 | SCV004208291 | likely pathogenic | Retinitis pigmentosa 39 | 2023-09-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001224891 | SCV001923890 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001224891 | SCV001974258 | pathogenic | not provided | no assertion criteria provided | clinical testing |